Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2

NCT03209869 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped resources limited due to COVID-19

Conditions

Neuroblastoma
Relapsed Neuroblastoma
Recurrent Neuroblastoma
Osteosarcoma

Interventions

BIOLOGICAL: Ex vivo Expanded and Activated Haploidentical Donor NK Cells
BIOLOGICAL: Hu14.18-IL2

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]